Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses
Tamai, Toshiyuki, Hayato, Seiichi, Hojo, Seiichiro, Suzuki, Takuya, Okusaka, Takuji, Ikeda, Kenji, Kumada, Hiromitsu
Published in Journal of clinical pharmacology (01.09.2017)
Published in Journal of clinical pharmacology (01.09.2017)
Get full text
Journal Article
Lenvatinib, gemcitabine, and oxaliplatin for 67 patients with fibrolamellar carcinoma
Stockwell, Tom, Tasse, Jordan C, Humar, Abhinav, Kato, Tom, Fisher, Oliver M, Yamashiro, Darrell, Davison, Reid Michael, Cornelius, Albert, Swasey, Susanne M., Dixon, Matthew, Seder, Christopher W., Schadde, Erik
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Metabolic effects of lenvatinib in subjects with advanced thyroid cancer: Is there an impact on lipid metabolism?
Maranghi, Marianna, Acitelli, Elisa, Minicocci, Ilenia, Verrienti, Antonella, Sponziello, Maria Luisa, Pecce, Valeria, Iurato, Chiara, Durante, Cosimo, Grani, Giorgio
Published in Atherosclerosis (01.08.2024)
Published in Atherosclerosis (01.08.2024)
Get full text
Journal Article
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy
Locati, L.D., Piovesan, A., Durante, C., Bregni, M., Castagna, M.G., Zovato, S., Giusti, M., Ibrahim, T., Puxeddu, E., Fedele, G., Pellegriti, G., Rinaldi, G., Giuffrida, D., Verderame, F., Bertolini, F., Bergamini, C., Nervo, A., Grani, G., Rizzati, S., Morelli, S., Puliafito, I., Elisei, R.
Published in European journal of cancer (1990) (01.09.2019)
Published in European journal of cancer (1990) (01.09.2019)
Get full text
Journal Article
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life
Marotta, Vincenzo, Rocco, Domenico, Crocco, Anna, Deiana, Maria Grazia, Martinelli, Ruggero, Di Gennaro, Francesca, Valeriani, Mariafelicia, Valvano, Luca, Caleo, Alessia, Pezzullo, Luciano, Faggiano, Antongiulio, Vitale, Mario, Monti, Salvatore
Published in The journal of clinical endocrinology and metabolism (16.09.2024)
Published in The journal of clinical endocrinology and metabolism (16.09.2024)
Get full text
Journal Article
SiRNA-HIF-1α delivered by attenuated Salmonella enhances the efficacy of Lenvatinib against hepatocellular carcinoma
Chen, Pengfei, Wang, Yanling, Zhu, Xingshu, Huang, Yujing, Chen, Jinwei, Sun, Hao, Wang, Yang, Zhao, Shenning, You, Yiqing, Wu, Yufei, Yang, Tongguo, Wei, Tian, Duan, Xuhua, Zhao, Tiesuo, Jia, Huijie, Ren, Jianzhuang
Published in International immunopharmacology (30.03.2024)
Published in International immunopharmacology (30.03.2024)
Get full text
Journal Article
Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects
Li, Jiaming, Wang, Xiaoqian, Ning, Chen, Wang, Zhaoyu, Wang, Yao, Zheng, Ming, Zhang, Siliang, Lu, Yang, Zhang, Yongjie, Li, Ning, Chen, Xijing, Zhao, Di
Published in European journal of clinical pharmacology (01.08.2020)
Published in European journal of clinical pharmacology (01.08.2020)
Get full text
Journal Article
Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome
Fuchigami, Akira, Imai, Yukinori, Uchida, Yoshihito, Uchiya, Hiroshi, Fujii, Yohei, Nakazawa, Manabu, Ando, Satsuki, Sugawara, Kayoko, Nakayama, Nobuaki, Tomiya, Tomoaki, Mochida, Satoshi
Published in PloS one (10.04.2020)
Published in PloS one (10.04.2020)
Get full text
Journal Article
Effects of diet and gender on the pharmacokinetics of oral lenvatinib: A clinical trial in healthy Chinese participants
Wei, Yilin, Yu, Yuan, Zhang, Wenyu, Mu, Hongli, He, Kun, Wen, Qing, Zhang, Xiaoran
Published in International journal of clinical pharmacology and therapeutics (01.11.2023)
Published in International journal of clinical pharmacology and therapeutics (01.11.2023)
Get full text
Journal Article
Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus
Wu, Hong-Xiao, Ding, Xiao-Yan, Xu, Ya-Wen, Yu, Ming-Hua, Li, Xiao-Mi, Deng, Na, Chen, Jing-Long
Published in World journal of gastroenterology : WJG (28.02.2024)
Published in World journal of gastroenterology : WJG (28.02.2024)
Get full text
Journal Article
A patent review on efficient strategies for the total synthesis of pazopanib, regorafenib and lenvatinib as novel anti-angiogenesis receptor tyrosine kinase inhibitors for cancer therapy
Shiri, Pezhman, Ramezanpour, Sorour, Amani, Ali Mohammad, Dehaen, Wim
Published in Molecular diversity (01.10.2022)
Published in Molecular diversity (01.10.2022)
Get full text
Journal Article
Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction
Sueta, Daisuke, Suyama, Koichi, Sueta, Aiko, Tabata, Noriaki, Yamashita, Takayoshi, Tomiguchi, Mai, Takeshita, Takashi, Yamamoto-Ibusuki, Mutsuko, Yamamoto, Eiichiro, Izumiya, Yasuhiro, Kaikita, Koichi, Yamamoto, Yutaka, Hokimoto, Seiji, Iwase, Hirotaka, Tsujita, Kenichi
Published in Atherosclerosis (01.05.2017)
Published in Atherosclerosis (01.05.2017)
Get full text
Journal Article
Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study
Matsuyama, Chihiro, Enokida, Tomohiro, Ueda, Yuri, Suzuki, Shinya, Fujisawa, Takao, Ito, Kazue, Okano, Susumu, Tahara, Makoto
Published in Frontiers in oncology (11.10.2023)
Published in Frontiers in oncology (11.10.2023)
Get full text
Journal Article
Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer
Onaga, Ryutaro, Enokida, Tomohiro, Okano, Susumu, Fujisawa, Takao, Tanaka, Nobukazu, Hoshi, Yuta, Kishida, Takuma, Tanaka, Hideki, Sato, Masanobu, Takeshita, Naohiro, Kuboki, Ryo, Nishino, Hiroshi, Ito, Makoto, Tahara, Makoto
Published in International journal of clinical oncology (01.10.2024)
Published in International journal of clinical oncology (01.10.2024)
Get full text
Journal Article
Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018–2021) compared to the sorafenib era (2008–2018)
Lim, Chloe A., Amaro, Carla P., Ding, Philip Q., Cheung, Winson Y., Tam, Vincent C.
Published in Cancer medicine (Malden, MA) (01.07.2024)
Published in Cancer medicine (Malden, MA) (01.07.2024)
Get full text
Journal Article
Tailored management of advanced thyroid cancer patients treated with lenvatinib or vandetanib: the role of a multimodal approach
Nervo, Alice, Ferrari, Matteo, Vaccaro, Elisa, Migliore, Enrica, Gruosso, Giovanni, Roux, Anna, Piovesan, Alessandro, Arvat, Emanuela
Published in Endocrine (01.02.2025)
Published in Endocrine (01.02.2025)
Get full text
Journal Article
Phase II study of lenvatinib plus pembrolizumab for patients with immunotherapy-naive advanced gastric cancer following first line therapy
Lee, Jonathan W, Becker, Daniel Jacob, Siolas, Despina, Beri, Nina, Ryan, Theresa, Kozuch, Peter, Yu, Shun, Levinson, Benjamin A., Goldberg, Judith D., Leichman, Lawrence P., Oberstein, Paul Eliezer
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article